Periodic Reporting for period 3 - EuroBioTox (European programme for the establishment of validated procedures for the detection and identification of biological toxins)
Période du rapport: 2019-12-01 au 2021-05-31
EuroBioTox focuses on four main objectives:
1) Evaluate currently available analytical tools, methods, reagents, and matrices using the expertise of the 13 core partners.
2) Improve validation and testing capabilities for biological toxin analysis across the EU.
3) Enable laboratories across the EU to further improve their analytical skills in detecting toxins.
4) Enable the replacement of animal experiments for the detection of BoNT.
In WP2 proprietary tools and reagents for the detection of toxins were produced and made available in a EuroBioTox repository accessible for all network partners. In a comprehensive validation study, selected detection methods based on reagents from the repository were evaluated in detail.
Within WP3, seven proficiency tests (PTs) on different biotoxins were organised, targeting either laboratory-based detection, identification and quantification of biotoxins or in-situ detection with up to 29 participating laboratories. The exercises highlighted technical capabilities of EuroBioTox network partners and demonstrated further room for technical advancement. Four more exercises are in preparation.
WP4, dedicated to the implementation of quality procedures, determined a set of criteria to prioritise applicants for different training programmes based on an online survey. A standardised PT protocol containing guidelines for PT organisation was produced, along with validation protocols for immunological and mass-spectrometry methods.
WP5 is focused on the organisation and evaluation of 19 training courses on ricin, abrin, STX, BoNT and SE toxins. Until now, 14 training courses on different methods, toxins and levels were successfully conducted including distance teaching courses, supporting capability building within the EuroBioTox network.
Based on a comprehensive threat analysis, forensic scenarios were developed in WP6 and information on European organisations with the ability to train first responders was compiled. Procedural guidelines for first responders on toxin sampling, detection and decontamination were developed and demonstrated at a workshop for first responders. Additionally, the development of a forensic peptide database is ongoing.
With respect to animal replacement methods, a recovery study for the evaluation of five different methods for BoNT detection against the current gold standard, the mouse bioassay, has been initiated in WP7. A panel of BoNT sero- and subtypes was produced and comprehensively characterised as basis for the comparison of different in vitro and ex vivo detection methods.
WP8 aims at the dissemination of information within the network and to relevant decision makers and scientists. To this end, a project website was established counting more than 35000 visitors so far, and three annual newsletters were released. 46 oral and 6 poster presentations, three scientific publications, a EuroBioTox brochure, two explanatory movies as well as different e-learning materials on detection methods for biotoxins were delivered.
WP9 is dedicated to the general coordination and management of the project, including all administrative and financial issues. This task covered, among others, the organisation of three face-to-face meetings and a series of virtual meetings so far.
In WP10 a number of documents highlighting relevant ethics issues were provided and information on ethics issues are continuously documented.
Overall, EuroBioTox aims at implementing a comprehensive mechanism of training, method sharing, improvement of quality assurance measures and proficiency testing. It is expected that the spreading of good analytical practices will improve preparedness and response planning at national and international level. Along this line, EuroBioTox will contribute to minimise potential health and security threats in the EU and will increase resilience of civil society by sound capacity building and technical improvement.